Plenary Session

382 Episodo

1. 2.13 BONUS! RCTs Supporting Approvals of Cancer Drugs by EMA with Dr. Huseyin Naci

   Publicado: 20/9/2019
2. 2.12 Questions of the Week, Ethics of RCTs, & Transmission and Medical Overuse with Dr. Dan Morgan

   Publicado: 17/9/2019
3. 2.11 Questions of the Week, When RCTs are Necessary, & AYA Oncology with Dr. Adam Duvall

   Publicado: 12/9/2019
4. 2.10 Questions of the Week: the USMLE Step 2 CK, the MKSAP, & Hematology/Oncology

   Publicado: 5/9/2019
5. 2.09 Questions of the Week & Informed Consent in Clinical Trials with Dr. Lynn Jansen

   Publicado: 28/8/2019
6. 2.08 Questions of the Week: the MKSAP, the USMLE Step 2 CK, & From a Med Student

   Publicado: 22/8/2019
7. 2.07 Translational Research & Physical Examination Pet Peeves with Dr. Adam Cifu

   Publicado: 16/8/2019
8. 2.06 Heart Failure, Choosing a Specialty, & the Bayesian Approach with Dr. Frank Harrell

   Publicado: 6/8/2019
9. 2.05 Reup! Cancer Screening 101 with Dr. Adam Obley

   Publicado: 31/7/2019
10. 2.04 Reup! Tumor-Treating Fields for Glioblastoma with Dr. Michael Hayes

    Publicado: 30/7/2019
11. 2.03 Dr. Charles Moertel and the Modern Oncologist & Cancer Screening 101 with Dr. Adam Obley

    Publicado: 23/7/2019
12. 2.02 BONUS! Improving Access to Prescription Drugs through Policy Change with Dr. Stacie Dusetzina

    Publicado: 17/7/2019
13. 2.01 Selinexor, ECHELON-2, Parachutes, Tumor-Treating Fields, & MedTwitter

    Publicado: 12/7/2019
14. 1.68 Voxeletor with Dr. Olson & Humanizing Cancer, Defining Cancer, and more with Dr. David Steensma

    Publicado: 5/7/2019
15. 1.67 MONALEESA-7 and the Cost of Cancer Drugs with Dr. Stacie Dusetzina

    Publicado: 27/6/2019
16. 1.66 Employing Medical Writers & Frequentist vs Bayesian Methods with Dr. Allen Pannell

    Publicado: 20/6/2019
17. 1.65 BONUS! Focusing and Building Your Presence on Twitter

    Publicado: 12/6/2019
18. 1.64 Effectiveness of Cancer Screening with Dr. Joaquín Chapa and POLO with Dr. Emerson Chen

    Publicado: 6/6/2019
19. 1.63 POLO, TITAN, & from ASCO: FDA Approval, Surrogate Endpoints, and Patient Experience

    Publicado: 4/6/2019
20. 1.62 Rates of Cancer Screening, BILCAP Outcry, Waterfall Plots and Response Rate, & Dr. Jeff Sharman

    Publicado: 23/5/2019